# Tolerability and Safety Study of FLUVAL P Monovalent Influenza Vaccine in Children

> **NCT01100294** · NA · COMPLETED · sponsor: **Fluart Innovative Vaccine Ltd, Hungary** · enrollment: 10 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Vaccination with FLUVAL P

## Key facts

- **NCT ID:** NCT01100294
- **Lead sponsor:** Fluart Innovative Vaccine Ltd, Hungary
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2010-04
- **Final completion:** 2010-05
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2012-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01100294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01100294, "Tolerability and Safety Study of FLUVAL P Monovalent Influenza Vaccine in Children". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01100294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*